PDMP & Opioid Enduring Module

Course ID: 24CE00123

Estimated Time to Complete: 240 minutes

Better Health Outcomes: Making The Most Of The PDMP!

Joseph Fibich, PharmD

Nothing to disclose

• Access and interpret the Nebraska PDMP data to inform and optimize prescribing decisions effectively.
• Conduct effective patient queries within the PDMP to assess patient prescription histories and identify potential misuse or abuse.
• Implement procedures to appropriately authorize and supervise delegates who access PDMP information on your behalf, ensuring compliance with regulatory guidelines.

Pharmacological Perspectives and Clinical Applications in Substance Use Disorders

Ardsley Congdon III, PharmD, BCPS, BCPP

Nothing to disclose

• Explain key pharmacological and pharmacokinetic aspects of medication therapies for substance use disorders.
• Distinguish clinically relevant drug interactions concerning medication therapies for substance use disorders.
• Formulate treatment plans for managing adverse drug effects to reduce barriers to treatment for substance use disorders.
• Review medications for treatment of opioid and alcohol withdrawal in outpatient settings.
• Apply pharmacological principles to complex patient scenarios to optimize outcomes with harm reduction as a central principal.

Pain Treatment Strategies for Patients with Opioid Use Disorder

Kimberly Haynes-Henson, MD

Nothing to disclose

• Discuss the efficacy and risks associated with opioid analgesics in chronic, non-cancer pain management, with an emphasis on strategies to decrease opioid prescribing.
• Explore non-pharmacological interventions as primary options for pain relief, considering their role in reducing reliance on opioids.
• Discuss the potential utilization of anti-seizure medications, antidepressants, and NSAIDs as alternatives to opioids for chronic, non-cancer pain management.
• Identify interventional options as adjunctive therapies to management of common pain complaints.

Clinical Application of Medications for Addiction Treatment

Kelly Gassman, MPAS, PA-C, CAQ-Psych

Nothing to disclose

• Examine the pharmacological properties of buprenorphine and its therapeutic role in addressing opioid use disorders.
• Discuss barriers to addiction treatment for opioid use disorders and other substance use disorders, considering the pharmacodynamics of treatment options.
• Summarize strategies utilizing pharmacotherapeutic approaches when treating addictions as derived from case-based scenarios.